DOI: http://dx.doi.org/10.18203/issn.2454-2156.IntJSciRep20161877

Prevalence of postpartum thyroiditis in women with gestational diabetes mellitus in Ardabil: North West of Iran

Manouchehr Iranparvar-Alamdari, Hosein Ghorbani Behrooz, Mostafa Alidousti

Abstract


Background: Gestational diabetes is the most common metabolic disorder during pregnancy and postpartum thyroiditis is a destructive thyroiditis that can cause serious complications for the mother and her child. The purpose of this study was to determine the prevalence of postpartum thyroiditis in women with gestational diabetes.

Methods: In this cross-sectional study, 86 cases satisfy inclusion criteria and gestational diabetes mellitus (GDM) and were evaluated for postpartum thyroiditis with thyroid stimulating hormone (TSH), T4, anti-TPO, T3RU tests. The groups with and without thyroiditis were compared and data was analyzed by statistical methods.

Results: There were 17 patients (19.8%) with postpartum thyroiditis, of whom 4 patients (23.5%) had hyperthyroidism, 9 patients (52.9%) were in the age group of 21 to 30 years, and 9 patients (52.9%) had a family history of diabetes.  Five patients (29.4%) with high anti-TPO level (P=0.022) and mean TSH and anti-TPO respectively, 2.8 (4.8) and 17.2 (35.9).

Conclusions: The results showed that higher level of anti TPO titer and family history of diabetes can be associated with a higher rate of postpartum thyroiditis, so it is recommended that postpartum thyroiditis to be examined in women with gestational diabetes who have these mentioned items.


Keywords


Gestational diabetes, Postpartum thyroiditis, Prevalence

Full Text:

PDF

References


Gary-Cunningham F, Norman F, Kenneth J, Larry C, Johns C , Katharine D. Willams obstetrics 21th ed- New York Mc Graw Hill. 2001;2:1359-79.

American Diabets Association. Report of the expert committee on the diagnoses and classification of diabetes mellitus. Diabets Care. 2007;20:1183-97.

Velkoska-Nakova V, Krstevska B, Dimitrovski CH, Simeonova S, Hadzi-Lega M, Serafimoski V. Prevalence of thyroid dysfunction and autoimmunity in pregnant women with gestational diabetes and diabetes type 1. Prilozi. 2010;31:51-9.

Damm P, Kuhl C, Buschard K. Prevalence and predictivevalue of islet cell antibodies and insulin autoantibodies inwomen with gestational diabetes. Diabetic Medicine. vol. 2004;11(6):558-63.

Carney LA, Quinlan JD, West JM. Thyroid disease in pregnancy. Am Fam Physician 2014 ;89:273-8.

Nicholson WK, Robinson KA, Smallridge RC. Prevalence of postpartum thyroid dysfunction: a quantitative review. Thyroid 2006;16:573-82.

Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007;92:S1-47.

Stagnaro-Green A. Postpartum thyroiditis. Best Pract Res Clin Endocrinol Metab 2004;18:303-16.

Azizi F. The occurrence of permanent thyroid failure in patients with subclinical postpartum thyroiditis. Eur J Endocrinol. 2005;153:367-71.

Tachi J, Amino N, Tamaki H. Long term follow-up and HLA association in patients with postpartum hypothyroidism. J Clin Endocrinol Metab. 1988;66:480-4.

Stagnaro-Green A. Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab 2012;97:334-42.

Lazarus JH, Hall R, Othman S, Parkes AB, Richards CJ, McCulloch B, et al. The clinical spectrum of postpartum thyroid disease. QJM. 1996;89:429-35.

Lazarus JH, Ammari F, Oretti R. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 1997;47:305-8.

Stuckey BG, Kent GN, Ward LC. Postpartum thyroid dysfunction and the long-term risk of hypothyroidism: results from a 12-year follow-up study of women with and without postpartum thyroid dysfunction. Clin Endocrinol (Oxf). 2010;73:389-95.

Lucas A, Pizarro E, Granada ML. Postpartum thyroiditis: long-term follow-up. Thyroid. 2005;15:1177-81.

Othman S, Phillips DI, Parkes AB, Harris B, Fung H, Darke C, et al. A long-term follow-up of postpartum thyroiditis. Clin Endocrinol (Oxf). 1990;32:559-64.

Lazarus JH, Othman S. Thyroid disease in relation to pregnancy. Clin Endocrinol (Oxf). 1991;34:91-8.

Harris B, Othman S, Davies JA. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ. 1992;305:152-6.

Miyake A, Tahara M, Koike K, Tanizawa O. Decrease in neonatal suckled milk volume in diabetic women. Eur J Obstet Gynecol Reprod Biol. 1989;33:49-53.

Alvarez-Marfany M, Roman SH, Drexler AJ.Long-termprospective study of postpartum thy-roiddysfunction inwomenwith insulindependent diabetesmellitus. J Clin Endocrinol Metab. 1994;79:10-6.

Bech K, Høier-Madsen M, Feldt-Rasmussen U. Thyroid function and autoimmune manifestations in insulin-dependent diabetes mellitus during and after pregnancy. Acta Endocrinol (Copenh). 1991;124(5):534-9.

Gerstein HC. Incidence of postpartum thyroid dysfunction in patientswith type I diabetesmellitus. Ann InternMed. 1993;118:419-23.

Shahbazian HB, Sarvghadi F, Azizi F. Prevalence and charac-teristics of postpartum thyroid dysfunction in Tehran. Eur J Endocrinol. 2001;145:397-401.

Gallas PR, Stolk RP, Bakker K. Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type 1. Eur J Endocrinol. 2002;147(4):443-51.

Triggiani V, Ciampolillo A, Guastamacchia E. Prospective study of post-partum thyroid immune dysfunctions in type 1 diabetic women and in a healthy control group living in a mild iodine deficient area. Immunopharmacol Immunotoxicol. 2004;26(2):215-24.

Sarvghadi F, Hedayati M, Mehrabi Y. Follow up of patientswith postpartumthyroiditis: a population-based study. En-docrine. 2005;27:279-82.

Marqusee E, Hill JA, Mandel SJ. Thyroiditis after pregnancy loss. J Clin Endocrinol Metab. 1997;82(8):2455-7.

Friedrich N, Schwarz S, Thonack J, John U, Wallaschofski H, Völzke H. Association between parity and autoimmune thyroiditis in a general female population. Autoimmunity. 2008;41(2):174-80.

Walsh JP, Bremner AP, Bulsara MK. Parity and the risk of autoimmune thyroid disease: a community-based study. J Clin Endocrinol Metab. 2005;90(9):5309-12.